[1] SHIFERAW W S,AKALU T Y,AYNALEM Y A.Risk factors for anemia in patients with chronic renal failure:A systematic review and meta-analysis[J].Ethiop J Health Sci,2020,30(5):829-842. [2] SAAR-KOVROV V,ZIDEK W,ORTH-ALAMPOUR S,et al.Reduction of protein-bound uraemic toxins in plasma of chronic renal failure patients:A systematic review[J].J Intern Med,2021,290(3):499-526. [3] 麦文顶,黄志敏,唐宇,等.三七注射液对慢性肾衰竭大鼠肠道菌群多样性结构的影响研究[J].现代中西医结合杂志,2022,31(2):147-152,167. [4] 赵会承,赵艳梅,朱容,等.宣清导浊汤加味治疗下焦湿毒型慢性肾衰竭疗效及对肾功能,生活质量的影响[J].现代中西医结合杂志,2021,30(13):1446-1449. [5] 中华中医药学会.慢性肾衰竭诊疗指南[J].中国中医药现代远程教育,2011,9(9):132-133. [6] 郑筱萸. 中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:15-18. [7] 史耀勋. 肾衰宁胶囊治疗慢性肾衰竭非透析颈动脉钙化患者TNF-α及IL-6的影响[J].中国中西医结合肾病杂志,2022,23(1):80-81. [8] 赵会承,赵艳梅,朱容,等.宣清导浊汤加味治疗下焦湿毒型慢性肾衰竭疗效及对肾功能/生活质量的影响[J].现代中西医结合杂志,2021,30(13):1446-1449. [9] 付守强,冯慧,张莉唯,等.基于取象思维的中医清浊理论辨析[J].安徽中医药大学学报,2022,41(5):5-7. [10] POGGIO E D,MCCLELLAND R L,BLANK K N,et al.Kidney Precision Medicine Project.Systematic review and Meta-Analysis of native kidney biopsy complications[J].Clin J Am Soc Nephrol,2020,15(11):1595-1602. [11] GARCIA SANCHEZ J J,THOMPSON J,SCOTT D A,et al.Treatments for chronic kidney disease:A systematic literature review of randomized controlled trials[J].Adv Ther,2022 ,39(1):193-220. [12] 商永芳,徐倩,王会玲,等.中药仙灵脾对2型糖尿病大鼠炎症因子的影响[J].临床医药实践 2022,21(5):359-361. [13] 张艳红,安月鹏,石光煜.杨素清教授运用角药治疗掌跖脓疱病经验[J].环球中医药,2021,14(9):1642-1645. [14] HERNANDEZ G N,SEFFAH K,ZAMAN M A,et al.Unraveling the secrets behind the multidrug-resistant tuberculosis treatment outcome in chronic renal failure patients requiring hemodialysis:A systematic review[J].Cureus,2023,15(3):e36833. [15] 杨臻,郭桂芳.慢性肾脏病非肾脏替代治疗住院患者衰弱现状及其影响因素[J].中国护理管理,2022,22(6):868-873. [16] 赖莉敏,瞿礼萍,刘思莉,等.蚕沙提取物对缺铁性贫血小鼠铁代谢的影响及抗氧化作用研究[J].中药新药与临床药理,2021,32(5):627-631. |